z-logo
open-access-imgOpen Access
Genomewide Association betweenGLCCI1and Response to Glucocorticoid Therapy in Asthma
Author(s) -
Kelan G. Tantisira,
Jessica LaskySu,
Michishige Harada,
Amy Murphy,
Augusto A. Litonjua,
Blanca E. Himes,
Christoph Lange,
Ross Lazarus,
Jody Sylvia,
Barbara J. Klanderman,
Qing Duan,
Weiliang Qiu,
Tomomitsu Hirota,
Fernando D. Martínez,
David Mauger,
Christine A. Sorkness,
Stanley J. Szefler,
Stephen C. Lazarus,
Robert F. Lemanske,
Stephen P. Peters,
John J. Lima,
Yusuke Nakamura,
Mayumi Tamari,
Scott T. Weiss
Publication year - 2011
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0911353
Subject(s) - medicine , asthma , glucocorticoid , pharmacogenetics , inhaled corticosteroids , drug response , genome wide association study , association (psychology) , oncology , bioinformatics , genotype , genetics , pharmacology , single nucleotide polymorphism , gene , drug , biology , psychotherapist , psychology
The response to treatment for asthma is characterized by wide interindividual variability, with a significant number of patients who have no response. We hypothesized that a genomewide association study would reveal novel pharmacogenetic determinants of the response to inhaled glucocorticoids.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom